Join us at #CRT2026 to see AGENT™ DCB and Selution SLR™ under the microscope showing before and after simulated catheter tracking. Visit Boston Scientific’s Tech Suite to explore drug coating durability prior to inflation and why drug loss before treatment matters.

Are you attending #CRT2026? Come check out our interactive Next Gen Tech Suite! Showing you how we are advancing patient care and what’s next in cardiology. Learn more: qrco.de/bgdoAy#CRT2026

Hear from our experts as they highlight the latest clinical data. Make sure to check out these can't miss data sessions from your peers. Learn more: qrco.de/bgdoAy

Attending #THT2026? Join us March 3 for Heart Failure without Silos. From AFib in HFpEF to hemodynamic support in HRPCI, this session brings heart failure, EP, and interventional cardiology together. Add to your calendar: qrco.de/bgeJOC

Join Boston Scientific at #CRT2026 and dive into the future of cardiology. Explore our lineup of can’t-miss symposia and meet the experts sessions to see how we are advancing patient care and driving innovation. See the schedule: qrco.de/bgdoAy#CRT2026

Watch Drs. Yousefian & Aragon precisely steer the WATCHMAN TruSteer™ Access System to get deeper access into this complex appendage anatomy. During deployment, additional steering is applied by Dr. Yousefian to ensure the device is coaxial with the appendage ostium in its final position. #LAAC

Join interventional cardiology experts as they discuss IVUS as the gold standard for PCI imaging and how Automated Lesion Assessment (ALA) supports an efficient workflow for consistent, reproducible insights that support better patient outcomes. Watch the full discussion: qrco.de/bgdH2v

The WATCHMAN FLX™ Pro #LAAC Device gives your patients an effective option for long-term stroke protection without the burden of OACs. In the Pinnacle FLX U.S. IDE clinical trial, >96% of patients discontinued OAC after 45 days.*¹ Help more NVAF patients move beyond the prescription: qrco.de/bgdDZG

The right cardiac monitor can change everything. BodyGuardian™ MINI and MINI PLUS give you faster insights, less admin work, and a more comfortable experience for patients. Learn more: qrco.de/bgYQWq BodyGuardian™ MINI and MINI PLUS Indications, Safety, and Warnings: qrco.de/bfqd43

The patients we serve are the heart of our mission, and stories like Joyce’s inspire us to continue the WATCHMAN™ LAAC Implant journey. This #HeartMonth, we celebrate the dedicated HCPs who have helped over 600,000 AFib patients move beyond OACs for stroke-risk protection.

Recent data from the AGENT™ DCB Post-Approval Study demonstrates that AGENT shows in-hospital safety outcomes comparable to DES. This evidence reinforces clinical confidence in AGENT without compromising safety. Learn more about the study: qrco.de/bgauMk

Improved IVUS-guided PCI outcomes support critical clinical decisions. In a recent publication, Dr. Simon Walsh outlines the IVUS 123 Workflow, a simplified, standardized approach designed to support intuitive decision-making, reproducibility, and long-term PCI durability. 🔗 qrco.de/bgbY7m

Learn how the VersaCross™ Steerable Access Solution facilitates zero-exchange transseptal access-to-delivery of 8.5F left-heart therapies, eliminating the need for a fixed curve sheath: qrco.de/bgbyQG VersaCross™ Steerable Access Solution indications, safety and warnings: qrco.de/bs-vst

Long-term #PFA data matters. FARAPULSE™ PFA delivered. ADVENT LTO was the first clinical study to report outcomes out to 4 years from a randomized cohort of patients comparing PFA vs. thermal ablation, showing FARAPULSE™ PFA outperformed thermal. See the full study: qrco.de/bgbmX9

Today at #AFSymposium2026, Dr. Devi Nair shared her first clinical experience using the next-generation ACUNAV Luxera 4D ICE Catheter* in a WATCHMAN™ LAAC case. Developed in close collaboration with Siemens Healthineers, we're excited to continue advancing ICE imaging for WATCHMAN™ LAAC procedures.

Don't miss at #AFSymposium2026: Dr. Devi Nair will present her experience with a next-generation 4D ICE catheter used in a WATCHMAN FLX™Pro #LAAC case. 📆Friday, February 6 ⌚10AM - 12:30PM WATCHMAN FLX Pro Left Atrial Appendage Closure Device Indications, Safety, & Warnings: qrco.de/bg3esL#AFSymposium2026

When PVI durability matters, catheter design matters. In separate pivotal IDE studies, PVI durability among redo procedures in persistent AF patients at 12 months was reported. Explore PFA clinical data: qrco.de/bgbZ7x #Epeeps

📊Catch these Late-Breaking Clinical Science Sessions and other key FARAPULSE™ PFA Platform data releases at #AFSymposium2026 this weekend! View the full program here: qrco.de/bgatmg#AFSymposium2026

We’re heading to #AFSymposium2026 this weekend! Will we see you there? Explore our comprehensive electrophysiology portfolio, dive into clinical evidence, and see our vision for future innovation – all in the name of advancing patient outcomes. We’re looking forward to connecting with you!

This February, we celebrate #AmericanHeartMonth and recognize the vital role physicians play in advancing cardiovascular care. Together, we’re driving innovation and improving outcomes for patients with heart disease. 🫀

The ShortCUT trial data shows that WOLVERINE™ Cutting Balloon™ demonstrated significant cost savings in total procedural costs compared to IVL. See the cost comparison: qrco.de/bgYRiv WOLVERINE Coronary Cutting Balloon Indications, Safety, and Warnings: qrco.de/WOLVERINE

One platform. Two ways to monitor. Find out which BodyGuardian™ MINI device fits the patient and study needs. Find your patients right fit: qrco.de/bgYPxr BodyGuardian™ MINI and MINI PLUS Indications, Safety, and Warnings: qrco.de/bfqd43

CHAMPION-AF has been selected as Late-Breaking Science at #ACC26 in New Orleans. This landmark RCT (3,000 patients, ~150 global sites) evaluating WATCHMAN™ LAAC Implant vs. DOACs will be presented on Saturday, March 28. Learn more about CHAMPION-AF: qrco.de/bgZrz3

Introducing FARAPOINT™ Pulsed Field Ablation (PFA) Catheter—the first-and-only focal catheter designed and optimized for PFA. FARAPOINT creates deep, durable focal and linear-shaped lesions, for optimized point-by-point workflows for CTI ablations. Explore FARAPOINT: qrco.de/bgYvF8 #Epeeps

The FRACTURE IDE Trial has completed enrollment! The FRACTURE IDE Trial aims to assess the safety and efficacy of a novel intravascular lithotripsy system in patients undergoing PCI for the treatment of coronary artery disease with severely calcified lesions. clinicaltrials.gov/study/NCT061...

More than 500,000 patients have been treated with the FARAPULSE™ #PFA Platform, and over 600,000 patients with the WATCHMAN #LAAC Device worldwide. These proven therapies can be performed concomitantly, known as FARAWATCH™. Explore #FARAWATCH: qrco.de/bgX3MA

BodyGuardian™ MINI and MINI PLUS deliver waterproof monitoring, long battery life, and flexible adhesive options to maximize comfort and compliance while maintaining diagnostic accuracy. Learn more: qrco.de/bgX3UZ BodyGuardian™ MINI and MINI PLUS Indications, Safety, and Warnings: qrco.de/bfqd43

As of January 1, 2026, U.S Centers for Medicare & Medicaid Services (CMS) have reassigned Drug-Coated Balloon (DCB) PCI procedures from APC Level 2 to Level 3 under the Hospital Outpatient Prospective Payment System (OPPS). Learn about AGENT™ DCB: qrco.de/bgWfsd

Address #Afib symptoms and reduce stroke risk in one concomitant streamlined case with the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, also known as FARAWATCH™. Learn more about the #FARAWATCH approach: qrco.de/bgX2uh#Afib#FARAWATCH#LAAC #PulsedFieldAblation

Together, the FARAPULSE™ #PFA Platform and WATCHMAN FLX™ Pro #LAAC Device empower physicians to treat AFib and provide stroke protection—all in one streamlined case and recovery process. Learn more about this integrated approach—FARAWATCH™: qrco.de/bgX2uh#PFA#LAAC#FARAWATCH

Smarter cardiac monitoring starts with BodyGuardian™ MINI and MINI PLUS. Get full-range monitoring for more accurate data to support confident decisions. Learn more: qrco.de/bgX2ke BodyGuardian™ MINI and MINI PLUS Indications, Safety, and Warnings: qrco.de/bfqd43

See Dr. Bernabei's first case using contact sensing on the FARAVIEW™ Software Module. After 3 RF procedures that resulted in reconnection, Dr. Bernabei and the team at Lancaster General Hospital successfully ablated the PVs and PW using FARAWAVE™ NAV PFA Catheter. #PFAonFARAVIEW

Why did we choose paclitaxel for our AGENT™ DCB design? For higher drug transfer. Learn more: qrco.de/bgUugT AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1

COMING SOON: The FARAPULSE™ PFA Platform will be expanding to include the FARAPOINT™ PFA Catheter, upon FDA approval, a NAV-enabled PFA optimized catheter designed to create both focal and linear-shaped lesions. Prepare to enhance your PFA workflow with FARAPOINT. See how it works: qrco.de/bgVhhC

“For the first time we’ve got clinical data about #PFA in right atrial lesion sets...We demonstrated that there were no safety events, no coronary spasm..., no hemolysis related directly to the FARAPOINT™ Catheter, and high clinical success.” See the data: qrco.de/bgVg1g#PFA #Epeeps

NEW MANIFEST-US REAL-WORLD REGISTRY DATA presented at #AHA2025 reinforces the consistent safety and performance of FARAPULSE™ #PFA as demonstrated across over 70,000 patients in 8 real-world studies. #EPeeps

In a recent case, FARAVIEW™ Software Module displayed how contact sensing and FIELDTAG™ Technology enhance procedural confidence. Physicians can visualize catheter contact information and rotation, supporting an optimized PFA workflow. Learn more: qrco.de/bgTyY7 #PFAonFARAVIEW

We’ve reimagined what’s possible for #PFA — a fully integrated future that’s driving innovation and shaping what’s next. The FARAPULSE™ PFA Platform is a transformative leap forward. Built for the EP lab, it provides tools from transseptal access to ablation to real-time mapping.

#LAAC Case Highlight: Dr. Asad Cheema, Englewood Hospital & Medical Center, used the WATCHMAN TruSteer™ Access System to navigate this challenging anterior chicken wing appendage with prominent pectinate. He then successfully deployed the WATCHMAN FLX™ Pro Device, achieving complete closure.

Join us Dec. 5–7, in Washington, D.C. cvent.me/2a5BYn TransformAF EP Fellows Experience 2025 delivers immersive learning on the FARAPULSE™ PFA Platform and WATCHMAN FLX™ Pro LAAC Device, with case-based insights, panel discussions, & practical tips you can bring back to your practice. #EPeeps

See how imaging + vessel prep drive success in PCI with AGENT™ DCB. Top interventional cardiologists walk through key clinical cases. 🎥View the full case on EDUCARE: qrco.de/bgHo7U AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1

Boston Scientific is partnering with Siemens Healthineers on the workflow development and commercialization of a next-gen ACUNAV 4D ICE catheter designed to enable guidance from the right atrium, streamline workflows and simplify procedures. (1/2)

OPTIMIZE has begun!

Discover how UCHealth’s concomitant #PFA & #LAAC procedural approach is setting a new standard in AF management. Join us for a discussion on launching a concomitant practice, where clinicians share practical advice, unexpected challenges, and transformative impacts on AFib care & patient outcomes.

Transforming PCI with #IVUS! Discover how it enhances patient outcomes and leads to higher long-term survival rates. 🔗 Explore our clinical data: qrco.de/bgI5uw

Why do atrial arrhythmia (AA) burden and AA episode duration matter? 💭 In the ADVANTAGE AF Phase II trial, the LUX-Dx™ Insertable Cardiac Monitor Systems (ICM) measured AA burden and longest AA episode duration—two powerful predictors of clinical success and healthcare utilization:

The LUX-Dx II+ AT algorithm can detect Atrial Tachycardia, Atrial Flutter, Atrial Fibrillation, sinus tachycardia or any other rhythms without compromising the AF algorithm’s detection performance. Learn more: qrco.de/bgFrUP Safety info: qrco.de/bfqd4c

What does modern PCI look like with AGENT™ DCB? 🎥Watch expert-led case studies showcasing the importance of imaging and vessel prep in DCB cases. EDUCARE has the full story: ttps://qrco.de/bgHnu0 AGENT™ Drug-Coated Balloon Indications, Safety, and Warnings: qrco.de/AGENT1

📊 Just in from #TCT2025! In the SHORT-CUT trial, WOLVERINE™ Cutting Balloon was noninferior to intravascular lithotripsy (IVL) for post-PCI MSA at site of max calcium and cut total procedural cost by $3,632 ($9,409 vs $13,051; p < 0.001).

How are you helping your patients manage their stroke risk? Join us in supporting advancements in #stroke protection this #WorldStrokeDay. SENTINEL™ CPS and WATCHMAN™ #LAAC Device, are designed to reduce stroke risks and enhance the quality of patient care.